EMA – EU Law Enforcement

In 2015, the European Medicines Agency (EMA) celebrated its 20th anniversary, coinciding with the 50 years of pharmaceutical regulation in the European Union (EU). In the EU, pharmaceuticals are legislated at the EU level, but the enforcement of this legislation is typically left to the Member States. Yet also in this area we can see a trend of verticalization. This development has resulted in too complex procedures, with potential negative effects on accountability.

Continue reading “Complex procedures as hurdle to accountability: verticalization of pharmaceutical enforcement”

The Editors

The editors are Miroslava (Mira) Scholten, Laura Zoboli, Zlatina Georgieva and Kelly Blount. Mira is an Associate Professor of EU law at Utrecht University, a member of the scientific board of Osservatorio AIR, and a member of the Utrecht Centre for Regulation and Enforcement in Europe (RENFORCE). Laura is Assistant Professor at the University of Brescia. Zlatina is Assistant Professor in Competition, Regulation and Enforcement at Utrecht University. Kelly is a former Doctoral Researcher at the University of Luxembourg and a member of the Doctoral Training Unit on Multi-Level Enforcement.